Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-62.04	42.58	112.16
Graham Fair Price	42.95	36.82	25.76
PEG	-60.59	0.17	-0.42
Price/Book	9.45	1.09	1.00
Price/Cash Flow	70.79	-75.65	44.30
Prices/Earnings	-45.90	17.23	31.85
Price/Sales	16.97	5.52	4.72
Price/FCF	70.79	-75.65	44.30
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	0.26	0.37	0.37
Operating Margin	104.13	0.12	0.06
ROA	103.50	< 0.005	< 0.005
ROE	< 0.005	0.02	102.33
ROIC	< 0.005	0.01	142.24
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	< 0.005	0.01	-42.43
Dividends QOQ	< 0.005	0.11	19797.91
EBIT QOQ	-0.72	0.90	24.78
EPS QOQ	-0.76	1.04	37.28
FCF QOQ	-0.46	-1.64	-255.21
Revenue QOQ	-0.15	-0.07	54.74
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	41.08	48.00	16.85
Days Sales Outstanding (DSO)	28.36	35.22	24.21
Inventory Turnover	2.19	1.87	-14.42
Debt/Capitalization	0.32	0.32	-0.19
Quick Ratio	0.43	0.38	-10.64
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	61.38	61.68	0.50
Cash	4.04	2.16	-46.67
Capex	-0.83	-1.01	-22.33
Free Cash Flow	1.38	-0.89	-35.60
Revenue	12.98	12.21	-5.96
Naive Interpretation	member

05 - Per Share Metrics · Bad

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	0.70	0.69	-0.43
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	32.64	12.21	-62.58
Naive Interpretation	Member

06 - Financial Health · Bad

Rating